Celebrity Inventors
Actor Marlon Brando has four patents, all named "Drumhead tensioning device and method."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128682 | APOLIPOPROTEIN L- I VARIANTS AND THEIR USE An isolated human Apolipoprotein L-I corresponding to a wild type human Apolipoprotein sequence is modified by a deletion at its C-terminal end.... | 05/24/2012 |
| 20120045418 | PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE The present invention relates to a topical pharmaceutical preparation for treating an inflammatory skin condition, preferably a condition associated with ischemia, comprising a supernatant of a physiological solution obtainable by cultivating peripheral blood mononuclea... | 02/23/2012 |
| 20120027867 | Spray-Dried Blood Products and Methods of Making Same The present invention is directed to a method of preparing dehydrated blood products, comprising the steps of: (a) providing a hydrated blood product; (b) spray-drying the hydrated blood product to produce a dehydrated blood product, as well as dehydrated blood products... | 02/02/2012 |
| 20120016489 | TEXTURED BONE BLOCK IMPLANTS Implantable pliable bone blocks comprising a solid block of cortical bone characterized by a length, width and thickness, having a first and a second face on opposite sides of the block. The first and second faces have a plurality slot features. The angle of incidence o... | 01/19/2012 |
| 20120009248 | Preservation of Bioactive Materials By Spray Drying This invention provides methods and compositions to preserve bioactive materials in a matrix of powder particles. Methods provide high-pressure gas spraying and/or near supercritical spraying of formulations followed by drying in a stream of conditioned gas to form stab... | 01/12/2012 |
| 20110318424 | METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR) The present invention is directed to the use of modulators of the mammalian target of rapamycine (mTOR) pathway, glucose and/or glucose enhancers for treating retinal disorders and, in particular, for prolonging the viability of cone cells.... | 12/29/2011 |
| 20110244053 | Use a goat serum for veterinary treatment Methods for veterinary treatment of mammals are described, for treatment of conditions having an inflammatory component. The methods are particularly suited to treatment of cats, dogs, or horses.... | 10/06/2011 |
| 20110177015 | SKIN AND HAIR CARE USING EXTRACT FROM CONDITIONED MEDIUM CULTURED BY MESENCHYMAL STEM CELLS AND OTHER REGENERATIVE CELLS A method and composition for treating dermatological conditions and improving skin condition and helping hair to grow or thicken involves putting mesenchymal stem cells or other cells with regenerative properties into culture medium to induce secretion of beneficial fac... | 07/21/2011 |
| 20110177036 | WHOLE BLOOD CULTURES COMPRISING STIMULATED IMMUNE CELLS, AND USE THEREOF AS MEDICAMENTS The present invention relates to a whole-blood culture containing specific immunocompetent killer cells that are activated against tumor cells, viruses, bacteria and/or allergens, whereby the whole-blood culture consists of whole-blood and a culture medium at a ratio of... | 07/21/2011 |
| 20110086046 | Treatment of MS with goat serum A serum composition from a goat immunised with HIV contains anti-HLA antibody and is suited for palliative improvement of the condition of an animal.... | 04/14/2011 |
| 20100323029 | FIVE-COORDINATE NEUROGLOBIN AND USE THEREOF AS A BLOOD SUBSTITUTE Described herein is the finding that a mutant form of human neuroglobin (H64L) with a stable five-coordinate geometry reduces nitrite to nitric oxide approximately 2000-times faster than the wild type neuroglobin. Five-coordinate neuroglobin is also capable of binding a... | 12/23/2010 |
| 20100293624 | ELIMINATION OF N-GLUCOLYLNEURAMINIC ACID FROM ANIMAL PRODUCTS FOR HUMAN USE This application is in the field of sialic acid chemistry, metabolism, antigenicity, and the production of transgenic non-human mammals with altered sialic acid production. More particularly, this application relates to N-glycolylneuraminic acid (Neu5Gc) being an immuno... | 11/18/2010 |
| 20100266707 | METHOD OF TREATING CACHEXIA WITH THE REMOVAL OR INACTIVATION OF MACROPHAGE INHIBITORY CYTOKINE-1 A method of treating cachexia is disclosed involving the removal or inactivation of macrophage inhibitory cytokine-1 (MIC-1) present in the blood, plasma or serum of a cachexia subject. In one embodiment, the method comprises the steps of providing a suitable substrate ... | 10/21/2010 |
| 20100260815 | FLUID CONCENTRATOR, AUTOLOGOUS CONCENTRATED BODY FLUIDS, AND USES THEREOF The present invention provides devices and methods for concentrating a fluid and for treating a patient with the concentrated fluid. The concentrator apparatus includes a main housing (12) defining a separation chamber (14), a filter housing (48) co... | 10/14/2010 |
| 20100183590 | LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria The present invention pertains to the protection against malaria. More particularly, the invention is based on the characterization of a novel liver and sporozoite-stage P. falciparum antigen, referred to as LSA-5. This antigen is highly antigenic and the prevale... | 07/22/2010 |
| 20100143289 | UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF Compositions including topical formulations comprising secreted products obtained from the culture medium of human umbilical cord stem cells and particular combinations of components therefrom are provided for treatment of various dermatological conditions, such as adve... | 06/10/2010 |
| 20100112082 | Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides The present invention provides BoNT/B peptides, BoNT/B peptide compositions, tolerogizing compositions, immune response inducing compositions, as well as methods of determining immunoresistance to botulinum toxin therapy in an individual, methods of treating immunoresis... | 05/06/2010 |
| 20100021439 | METHODS AND COMPOSITIONS FOR TREATING INTERVERTEBRAL DISC DEGENERATION A fluid matrix comprising cross-linked remodelable collagen from a donor vertebrate animal is useful for regenerating hydrodynamic function in damaged intervertebral discs in vivo. The matrix may be injectable and may comprise cells and a plurality of purified cell grow... | 01/28/2010 |
| 20090252786 | Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor The present invention relates to a method of preventing or treating in a subject a disorder characterized in a reduced GABA receptor function by administering to the subject a therapeutically effective amount of a pharmacologically active blood serum product obtainable ... | 10/08/2009 |
| 20090220585 | Biological Active Blood Serum Fraction S-1-10, Methods for Producing It and Uses Thereof The present invention relates to a method for preparing a biological active fraction of blood serum, the biological active fraction (S-1-10) and a pharmaceutical composition comprising said fraction as well as uses thereof in the treatment of various diseases and condit... | 09/03/2009 |
| 20080299213 | AUGMENTATION AND REPAIR OF SPINCTER DEFECTS WITH CELLS INCLUDING ADIPOCYTIC CELLS An embodiment of the invention includes methods for the long-term augmentation and/or repair of skin defects (scars, skin laxness, skin thinning, and skin augmentation), cellulite, breast tissue, wounds and burns, urological and gastroesophageal sphincter structures, he... | 12/04/2008 |
| 20080299212 | Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum The present invention relates to a pharmaceutical agent for treating Avellino corneal dystrophy, and more particularly, to a pharmaceutical composition for treating Avellino corneal dystrophy comprising pharmaceutically effective amount of blood plasma or serum as an ac... | 12/04/2008 |
| 20080206302 | Cell-Free Graft The invention proposes a cell-free graft, comprising (i) a cohesive, structure-forming matrix with open porosity made from a biologically and pharmaceutically acceptable material and (ii) serum. In one particularly preferred embodiment, the... | 08/28/2008 |
| 20080193386 | Compositions for Treating Alopecia or Promoting Hair Growth The present invention relates to a composition for treating alopecia or promoting hair growth, which contains the blood plasma or serum as an active ingredient. The inventive composition is effective in hair growth, hair growth promotion and hair loss prevention.... | 08/14/2008 |
| 20080152721 | Augmentation and repair of spincter defects with cells including adipocytic cells An embodiment of the invention includes methods for the long-term augmentation and/or repair of skin defects (scars, skin laxness, skin thinning, and skin augmentation), cellulite, breast tissue, wounds and burns, urological and gastroesophageal sphincter structures, he... | 06/26/2008 |
| 20080145444 | Blood product from crocodylian species as a feed supplement for weanling pigs and poultry hatchlings The present invention is a feed supplement consisting of a blood product from at least one Crocodylian species such as the American alligator (Alligator mississippiensis). The blood product is whole blood, hemolyzed blood, serum or plasma. The feed supplement is ... | 06/19/2008 |
| 20070160680 | Fluid composition used to stimulate human synovial fluid An artificial synovial fluid comprising a serum, a chelator, and a buffer is provided. In particular embodiments, the artificial synovial fluid may further comprise an antibiotic. The artificial synovial fluid is generally used in tribological testing of medical device ... | 07/12/2007 |
| 20070110817 | Biological active blood serum obtained by electrostimulation The present invention relates to a method for preparing a blood serum product, the blood serum product and a pharmaceutical composition comprising said blood serum product as well as uses thereof in the treatment of various diseases and conditions, including epileptic s... | 05/17/2007 |
| 20070048387 | Tissue disruption treatment and composition for use thereof The present invention relates to an agent having activity in the treatment of a tissue disruption. In particular the present invention relates to a composition comprising an effective amount of an active fraction having tissue healing properties ... | 03/01/2007 |
| 20060257496 | Use of a biological active blood serum for the treatment of stroke The present invention relates to the use of a pharmacologically active blood serum product producible by a method comprising electrostimulation of a non-human animal, withdrawal of blood from said animal, isolation of serum from said blood, and gamma irradiation of said... | 11/16/2006 |
| 20060204589 | Bear derived isolate and method A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not unlike... | 09/14/2006 |
| 20060182811 | Analgesic and anti-inflammatory composition The present invention discloses a composition that contains (1) an effective amount of an analgesically and/or anti-inflammatory active fraction separated from a mixture of plasma and/or serum, and (2) at least one metal, metal ion or metal salt, in which the mixture ha... | 08/17/2006 |
| 20060177515 | Method of producing autogenous or allogenic blood serum and related logistics A method of producing blood serum containing prophylactically or therapeutically active proteins, including obtaining blood from a patient, incubating the blood at a suitable temperature to induce production of prophylactically or therapeutically active proteins, and re... | 08/10/2006 |
| 20050053605 | Methods and compositions for treating herpes infections A method of treatment or prophylaxis of herpes infections and associated disease states by administration of compositions comprising immunoglobulins. Methods comprising intravenous and topical administration of immunoglobulins are provided. ... | 03/10/2005 |
